Neurotrophic factor delivery as a protective treatment for glaucoma

Experimental Eye Research

Volumn 93, Issue 2, 2011, Pages 196-203

  Johnson, Thomas V ^a,b,c   Bull, Natalie D ^a,b   Martin, Keith R ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

Cell transplantation; Gene therapy; Glaucoma; Neuroprotection; Neurotrophic factor; Neurotrophin; Slow release

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR;

ARTICLE; CELL TRANSPLANTATION; DRUG DELIVERY SYSTEM; GENE THERAPY; GLAUCOMA; HUMAN; NEUROPROTECTION; PATHOGENESIS; PRIORITY JOURNAL; RETINA CELL; RETINA GANGLION CELL; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; GENE THERAPY; GLAUCOMA; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS; HUMANS; NERVE GROWTH FACTORS; OPTIC NERVE DISEASES;

EID: 79955064720     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2010.05.016     Document Type: Article

References (105)

1. Agarwal N., Agarwal R., Kumar D.M., Ondricek A., Clark A.F., Wordinger R.J., Pang I.H. Comparison of expression profile of neurotrophins and their receptors in primary and transformed rat retinal ganglion cells. Mol. Vis. 2007, 13:1311-1318.
2. Anderson D.R., Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest. Ophthalmol. 1974, 13(10):771-783.
3. Arnhold S., Absenger Y., Klein H., Addicks K., Schraermeyer U. Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245(3):414-422.
4. Bainbridge J.W., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., Viswanathan A., Holder G.E., Stockman A., Tyler N., Petersen-Jones S., Bhattacharya S.S., Thrasher A.J., Fitzke F.W., Carter B.J., Rubin G.S., Moore A.T., Ali R.R. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358(21):2231-2239.
5. Beltran W.A., Zhang Q., Kijas J.W., Gu D., Rohrer H., Jordan J.A., Aguirre G.D. Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor alpha (CNTFRalpha). Invest. Ophthalmol. Vis. Sci. 2003, 44(8):3642-3649.
6. Benowitz L.I., Yin Y. Combinatorial treatments for promoting axon regeneration in the CNS: strategies for overcoming inhibitory signals and activating neurons' intrinsic growth state. Dev. Neurobiol. 2007, 67(9):1148-1165.
7. Benowitz L., Yin Y. Rewiring the injured CNS: lessons from the optic nerve. Exp. Neurol. 2008, 209(2):389-398.
8. Berry M., Ahmed Z., Lorber B., Douglas M., Logan A. Regeneration of axons in the visual system. Restor. Neurol. Neurosci. 2008, 26(2-3):147-174.
9. Bhattacharyya A., Watson F.L., Bradlee T.A., Pomeroy S.L., Stiles C.D., Segal R.A. Trk receptors function as rapid retrograde signal carriers in the adult nervous system. J. Neurosci. 1997, 17(18):7007-7016.
10. Bourges J.L., Bloquel C., Thomas A., Froussart F., Bochot A., Azan F., Gurny R., BenEzra D., Behar-Cohen F. Intraocular implants for extended drug delivery: therapeutic applications. Adv. Drug Deliv. Rev. 2006, 58(11):1182-1202.
11. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., Osborne N.N., Reichenbach A. Muller cells in the healthy and diseased retina. Prog. Retin. Eye Res. 2006, 25(4):397-424.
12. Bull N.D., Martin K.R. Optic nerve restoration: new perspectives. J. Glaucoma 2007, 16(5):506-511.
13. Bull N.D., Johnson T.V., Martin K.R. Stem cells for neuroprotection in glaucoma. Prog. Brain Res. 2008, 173:511-519.
14. Bull N.D., Irvine K.A., Franklin R.J., Martin K.R. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2009, 50(9):4244-4253.
15. Cao W., Wen R., Li F., Lavail M.M., Steinberg R.H. Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina. Exp. Eye Res. 1997, 65(2):241-248.
16. Cao W., Li F., Steinberg R.H., Lavail M.M. Development of normal and injury-induced gene expression of aFGF, bFGF, CNTF, BDNF, GFAP and IGF-I in the rat retina. Exp. Eye Res. 2001, 72(5):591-604.
17. Chao M., Casaccia-Bonnefil P., Carter B., Chittka A., Kong H., Yoon S.O. Neurotrophin receptors: mediators of life and death. Brain Res. Brain Res. Rev. 1998, 26(2-3):295-301.
18. Chaudhary P., Ahmed F., Quebada P., Sharma S.C. Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res. Mol. Brain Res. 1999, 67(1):36-45.
19. Chen H., Weber A.J. Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats. Brain Res. 2004, 1011(1):99-106.
20. Coassin M., Lambiase A., Sposato V., Micera A., Bonini S., Aloe L. Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246(12):1743-1749.
21. Collaborative-Normal-Tension-Glaucoma-Study-Group Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 1998, 126(4):487-497.
22. Crigler L., Robey R.C., Asawachaicharn A., Gaupp D., Phinney D.G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 2006, 198(1):54-64.
23. Di Polo A., Aigner L.J., Dunn R.J., Bray G.M., Aguayo A.J. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc. Natl. Acad. Sci. USA 1998, 95(7):3978-3983.
24. Frank L., Ventimiglia R., Anderson K., Lindsay R.M., Rudge J.S. BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. Eur. J. Neurosci. 1996, 8(6):1220-1230.
25. Fu Q.L., Hu B., Wu W., Pepinsky R.B., Mi S., So K.F. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Invest. Ophthalmol. Vis. Sci. 2008, 49(3):975-985.
26. Fu Q.L., Li X., Yip H.K., Shao Z., Wu W., Mi S., So K.F. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma. Neuroscience 2009, 162(2):375-382.
27. Garcia M., Forster V., Hicks D., Vecino E. In vivo expression of neurotrophins and neurotrophin receptors is conserved in adult porcine retina in vitro. Invest. Ophthalmol. Vis. Sci. 2003, 44(10):4532-4541.
28. Guo Y., Johnson E., Cepurna W., Jia L., Dyck J., Morrison J.C. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?. Exp. Eye Res. 2009, 89(6):921-933.
29. Hauck S.M., Kinkl N., Deeg C.A., Swiatek-de Lange M., Schoffmann S., Ueffing M. GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol. Cell Biol. 2006, 26(7):2746-2757.
30. Herzog K.H., von Bartheld C.S. Contributions of the optic tectum and the retina as sources of brain-derived neurotrophic factor for retinal ganglion cells in the chick embryo. J. Neurosci. 1998, 18(8):2891-2906.
31. Hu Y., Cho S., Goldberg J.L. Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2010, 51(3):1747-1754.
32. Ikeda N., Nonoguchi N., Zhao M.Z., Watanabe T., Kajimoto Y., Furutama D., Kimura F., Dezawa M., Coffin R.S., Otsuki Y., Kuroiwa T., Miyatake S. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 2005, 36(12):2725-2730.
33. Inoue Y., Iriyama A., Ueno S., Takahashi H., Kondo M., Tamaki Y., Araie M., Yanagi Y. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp. Eye Res. 2007, 85(2):234-241.
34. Iwabe S., Moreno-Mendoza N.A., Trigo-Tavera F., Crowder C., Garcia-Sanchez G.A. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma. Vet. Ophthalmol. 2007, 10(Suppl. 1):12-19.
35. Jaffe G.J., Martin D., Callanan D., Pearson P.A., Levy B., Comstock T. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 2006, 113(6):1020-1027.
36. Ji J.Z., Elyaman W., Yip H.K., Lee V.W., Yick L.W., Hugon J., So K.F. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur. J. Neurosci. 2004, 19(2):265-272.
37. Jiang C., Moore M.J., Zhang X., Klassen H., Langer R., Young M. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Mol. Vis. 2007, 13:1783-1792.
38. Johnson E.C., Guo Y., Cepurna W.O., Morrison J.C. Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models. Exp. Eye Res. 2009, 88(4):808-815.
39. Johnson T.V., Bull N.D., Hunt D.P., Marina N., Tomarev S.I., Martin K.R. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2010, 51(4):2051-2059.
40. Karlsson M., Lindqvist N., Mayordomo R., Hallbook F. Overlapping and specific patterns of GDNF, c-ret and GFR alpha mRNA expression in the developing chicken retina. Mech. Dev. 2002, 114(1-2):161-165.
41. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009, 4(3):206-216.
42. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Gordon M.O. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120(6):701-713. discussion 829-730.
43. Kassis I., Grigoriadis N., Gowda-Kurkalli B., Mizrachi-Kol R., Ben-Hur T., Slavin S., Abramsky O., Karussis D. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 2008, 65(6):753-761.
44. Kim D.H., Kim H.S., Ahn M.D., Chun M.H. Ganglion cell death in rat retina by persistent intraocular pressure elevation. Korean J. Ophthalmol. 2004, 18(1):15-22.
45. Kim H.J., Lee J.H., Kim S.H. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J. Neurotrauma 2010, 27(1):131-138.
46. Knox D.L., Eagle R.C., Green W.R. Optic nerve hydropic axonal degeneration and blocked retrograde axoplasmic transport: histopathologic features in human high-pressure secondary glaucoma. Arch. Ophthalmol. 2007, 125(3):347-353.
47. Ko M.L., Hu D.N., Ritch R., Sharma S.C. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2000, 41(10):2967-2971.
48. Ko M.L., Hu D.N., Ritch R., Sharma S.C., Chen C.F. Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci. Lett. 2001, 305(2):139-142.
49. Kong G.Y., Van Bergen N.J., Trounce I.A., Crowston J.G. Mitochondrial dysfunction and glaucoma. J. Glaucoma 2009, 18(2):93-100.
50. Kuppermann B.D., Blumenkranz M.S., Haller J.A., Williams G.A., Weinberg D.V., Chou C., Whitcup S.M. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch. Ophthalmol. 2007, 125(3):309-317.
51. Kurozumi K., Nakamura K., Tamiya T., Kawano Y., Kobune M., Hirai S., Uchida H., Sasaki K., Ito Y., Kato K., Honmou O., Houkin K., Date I., Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 2004, 9(2):189-197.
52. Lambiase A., Aloe L., Centofanti M., Parisi V., Mantelli F., Colafrancesco V., Manni G.L., Bucci M.G., Bonini S., Levi-Montalcini R. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc. Natl. Acad. Sci. USA 2009.
53. Lebrun-Julien F., Morquette B., Douillette A., Saragovi H.U., Di Polo A. Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol. Cell Neurosci. 2009, 40(4):410-420.
54. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59(4):514-523.
55. Li N., Li X.R., Yuan J.Q. Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247(4):503-514.
56. Libby R.T., Li Y., Savinova O.V., Barter J., Smith R.S., Nickells R.W., John S.W. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005, 1(1):17-26.
57. Liu H., Honmou O., Harada K., Nakamura K., Houkin K., Hamada H., Kocsis J.D. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006, 129(Pt 10):2734-2745.
58. Liu X., Clark A.F., Wordinger R.J. Expression of ciliary neurotrophic factor (CNTF) and its tripartite receptor complex by cells of the human optic nerve head. Mol. Vis. 2007, 13:758-763.
59. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., Banfi S., Marshall K.A., Testa F., Surace E.M., Rossi S., Lyubarsky A., Arruda V.R., Konkle B., Stone E., Sun J., Jacobs J., Dell'Osso L., Hertle R., Ma J.X., Redmond T.M., Zhu X., Hauck B., Zelenaia O., Shindler K.S., Maguire M.G., Wright J.F., Volpe N.J., McDonnell J.W., Auricchio A., High K.A., Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358(21):2240-2248.
60. Maguire A.M., High K.A., Auricchio A., Wright J.F., Pierce E.A., Testa F., Mingozzi F., Bennicelli J.L., Ying G.S., Rossi S., Fulton A., Marshall K.A., Banfi S., Chung D.C., Morgan J.I., Hauck B., Zelenaia O., Zhu X., Raffini L., Coppieters F., De Baere E., Shindler K.S., Volpe N.J., Surace E.M., Acerra C., Lyubarsky A., Redmond T.M., Stone E., Sun J., McDonnell J.W., Leroy B.P., Simonelli F., Bennett J. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009, 374(9701):1597-1605.
61. Mansoor S., Kuppermann B.D., Kenney M.C. Intraocular sustained-release delivery systems for triamcinolone acetonide. Pharm. Res. 2009, 26(4):770-784.
62. Martin K.R., Quigley H.A., Zack D.J., Levkovitch-Verbin H., Kielczewski J., Valenta D., Baumrind L., Pease M.E., Klein R.L., Hauswirth W.W. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2003, 44(10):4357-4365.
63. Martin K.R., Quigley H.A., Valenta D., Kielczewski J., Pease M.E. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp. Eye Res. 2006, 83(2):255-262.
64. McGill T.J., Prusky G.T., Douglas R.M., Yasumura D., Matthes M.T., Nune G., Donohue-Rolfe K., Yang H., Niculescu D., Hauswirth W.W., Girman S.V., Lund R.D., Duncan J.L., LaVail M.M. Intraocular CNTF reduces vision in normal rats in a dose-dependent manner. Invest. Ophthalmol. Vis. Sci. 2007, 48(12):5756-5766.
65. Minckler D.S., Bunt A.H., Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest. Ophthalmol. Vis. Sci. 1977, 16(5):426-441.
66. Moretto G., Xu R.Y., Walker D.G., Kim S.U. Co-expression of mRNA for neurotrophic factors in human neurons and glial cells in culture. J. Neuropathol. Exp. Neurol. 1994, 53(1):78-85.
67. Moretto G., Walker D.G., Lanteri P., Taioli F., Zaffagnini S., Xu R.Y., Rizzuto N. Expression and regulation of glial-cell-line-derived neurotrophic factor (GDNF) mRNA in human astrocytes in vitro. Cell Tissue Res. 1996, 286(2):257-262.
68. Mozaffarieh M., Grieshaber M.C., Orgul S., Flammer J. The potential value of natural antioxidative treatment in glaucoma. Surv. Ophthalmol. 2008, 53(5):479-505.
69. Pasutto F., Matsumoto T., Mardin C.Y., Sticht H., Brandstatter J.H., Michels-Rautenstrauss K., Weisschuh N., Gramer E., Ramdas W.D., van Koolwijk L.M., Klaver C.C., Vingerling J.R., Weber B.H., Kruse F.E., Rautenstrauss B., Barde Y.A., Reis A. Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma. Am. J. Hum. Genet. 2009, 85(4):447-456.
70. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2000, 41(3):764-774.
71. Pease M.E., Zack D.J., Berlinicke C., Bloom K., Cone F., Wang Y., Klein R.L., Hauswirth W.W., Quigley H.A. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2009, 50(5):2194-2200.
72. Petrs-Silva H., Dinculescu A., Li Q., Min S.H., Chiodo V., Pang J.J., Zhong L., Zolotukhin S., Srivastava A., Lewin A.S., Hauswirth W.W. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol. Ther. 2009, 17(3):463-471.
73. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 1980, 19(2):137-152.
74. Quigley H., Anderson D.R. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest. Ophthalmol. 1976, 15(8):606-616.
75. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90(3):262-267.
76. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 2000, 41(11):3460-3466.
77. Quigley H.A. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust. N. Z. J. Ophthalmol. 1995, 23(2):85-91.
78. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 1999, 18(1):39-57.
79. Riccio A., Pierchala B.A., Ciarallo C.L., Ginty D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 1997, 277(5329):1097-1100.
80. Rudzinski M., Wong T.P., Saragovi H.U. Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension. J. Neurobiol. 2004, 58(3):341-354.
81. Sadan O., Shemesh N., Barzilay R., Bahat-Stromza M., Melamed E., Cohen Y., Offen D. Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells 2008, 26(10):2542-2551.
82. Sadan O., Bahat-Stromza M., Barhum Y., Levy Y.S., Pisnevsky A., Peretz H., Ilan A.B., Bulvik S., Shemesh N., Krepel D., Cohen Y., Melamed E., Offen D. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev. 2009, 18(8):1179-1190.
83. Sadan O., Shemesh N., Cohen Y., Melamed E., Offen D. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. Isr. Med. Assoc. J. 2009, 11(4):201-204.
84. Salinas-Navarro M., Alarcon-Martinez L., Valiente-Soriano F.J., Jimenez-Lopez M., Mayor-Torroglosa S., Aviles-Trigueros M., Villegas-Perez M.P., Vidal-Sanz M. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 2010, 90(1):168-183.
85. Sariola H., Saarma M. Novel functions and signalling pathways for GDNF. J. Cell Sci. 2003, 116(Pt 19):3855-3862.
86. Sasaki M., Radtke C., Tan A.M., Zhao P., Hamada H., Houkin K., Honmou O., Kocsis J.D. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J. Neurosci. 2009, 29(47):14932-14941.
87. Schmeer C., Straten G., Kugler S., Gravel C., Bahr M., Isenmann S. Dose-dependent rescue of axotomized rat retinal ganglion cells by adenovirus-mediated expression of glial cell-line derived neurotrophic factor in vivo. Eur. J. Neurosci. 2002, 15(4):637-643.
88. Seki M., Lipton S.A. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog. Brain Res. 2008, 173:495-510.
89. Shi Z., Birman E., Saragovi H.U. Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo. Dev. Neurobiol. 2007, 67(7):884-894.
90. Sieving P.A., Caruso R.C., Tao W., Coleman H.R., Thompson D.J., Fullmer K.R., Bush R.A. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci. USA 2006, 103(10):3896-3901.
91. Simonelli F., Maguire A.M., Testa F., Pierce E.A., Mingozzi F., Bennicelli J.L., Rossi S., Marshall K., Banfi S., Surace E.M., Sun J., Redmond T.M., Zhu X., Shindler K.S., Ying G.S., Ziviello C., Acerra C., Wright J.F., McDonnell J.W., High K.A., Bennett J., Auricchio A. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol. Ther. 2010, 18(3):643-650.
92. Sposato V., Bucci M.G., Coassin M., Russo M.A., Lambiase A., Aloe L. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci. Lett. 2008, 446(1):20-24.
93. Sposato V., Parisi V., Manni L., Antonucci M.T., Di Fausto V., Sornelli F., Aloe L. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vis. Res. 2009, 49(1):54-63.
94. Valter K., Bisti S., Gargini C., Di Loreto S., Maccarone R., Cervetto L., Stone J. Time course of neurotrophic factor upregulation and retinal protection against light-induced damage after optic nerve section. Invest. Ophthalmol. Vis. Sci. 2005, 46(5):1748-1754.
95. Ward M.S., Khoobehi A., Lavik E.B., Langer R., Young M.J. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. J. Pharm. Sci. 2007, 96(3):558-568.
96. Wax M.B., Tezel G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp. Eye Res. 2009, 88(4):825-830.
97. Webster N.J., Pirrung M.C. Small molecule activators of the Trk receptors for neuroprotection. BMC Neurosci. 2008, 9(Suppl. 2):S1.
98. Wiggs J.L., Allingham R.R., Hossain A., Kern J., Auguste J., DelBono E.A., Broomer B., Graham F.L., Hauser M., Pericak-Vance M., Haines J.L. Genome-wide scan for adult onset primary open angle glaucoma. Hum. Mol. Genet. 2000, 9(7):1109-1117.
99. Wilkins A., Kemp K., Ginty M., Hares K., Mallam E., Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. 2009 March 27, [Epub ahead of print].
100. Wu Q., Zhang M., Song B.W., Lu B., Hu P. Expression of ciliary neurotrophic factor after induction of ocular hypertension in the retina of rats. Chin. Med. J. (Engl) 2007, 120(20):1825-1829.
101. Ye M., Chen S., Wang X., Qi C., Lu G., Liang L., Xu J. Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat. Neuroreport 2005, 16(6):581-584.
102. Yu S., Tanabe T., Dezawa M., Ishikawa H., Yoshimura N. Effects of bone marrow stromal cell injection in an experimental glaucoma model. Biochem. Biophys. Res. Commun. 2006, 344(4):1071-1079.
103. Yu S., Tanabe T., Yoshimura N. A rat model of glaucoma induced by episcleral vein ligation. Exp. Eye Res. 2006, 83(4):758-770.
104. Zhou Y., Pernet V., Hauswirth W.W., Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol. Ther. 2005, 12(3):402-412.
105. Zwart I., Hill A.J., Al-Allaf F., Shah M., Girdlestone J., Sanusi A.B., Mehmet H., Navarrete R., Navarrete C., Jen L.S. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Exp. Neurol. 2009, 216(2):439-448.